List of insiders holdings for RECURSION PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner | 2023-03-03 16:09:13 | 0 20,048,796 | 20,048,796 | Form 4 |
| Lux Ventures IV L.P. Lux Venture Partners IV LLC Lux Co-Invest Opportunities L.P. Lux Co-Invest Partners LLC Hebert Peter Wolfe Josh Former 10% Owner | 2021-12-09 20:57:21 | 17,287,095 0 | 17,287,095 | Form 4 |
| Gibson Christopher Chief Executive Officer | 2024-12-06 17:46:38 | 14,957,469 941,875 | 15,899,344 | Form 4 |
| Bogue Zachary Director 10% Owner | 2023-07-06 18:04:26 | 9,378 13,619,224 | 13,628,602 | Form 4 |
| Data Collective IV L.P. Data Collective IV GP LLC DCVC V GP LLC DCVC V L.P. DCVC Opportunity Fund II GP LLC DCVC Opportunity Fund II L.P. Ocko Matthew 10% Owner | 2022-02-14 15:23:34 | 13,619,224 0 | 13,619,224 | Form 13G |
| Borgeson Blake Director | 2024-11-14 19:19:48 | 7,066,113 0 | 7,066,113 | Form 4 |
| Secora Michael Chief Financial Officer | 2024-11-19 18:26:27 | 3,384,341 0 | 3,384,341 | Form 4 |
| Li Dean Y Director | 2024-10-04 18:29:59 | 75,703 3,112,844 | 3,188,547 | Form 4 |
| Marriott Tina President and COO | 2024-11-19 18:26:17 | 2,154,901 0 | 2,154,901 | Form 4 |
| Taylor Ben R Chief Financial Officer | 2024-12-20 16:16:57 | 2,048,635 0 | 2,048,635 | Form 4 |
| Khan Najat Chief R&D Commercial Officer | 2024-08-05 17:12:25 | 1,490,916 0 | 1,490,916 | Form 4 |
| MIC Capital Partners (Public) Parallel Cayman LP MIC Capital Management UK LLP MIC CAPITAL PARTNERS (PUBLIC) (US) IM LLC 10% Owner | 2021-11-03 16:50:12 | 0 1,388,889 | 1,388,889 | Form 3/A |
| Virani Shafique Chief Business Officer | 2024-01-18 18:39:02 | 796,610 0 | 796,610 | Form 4 |
| Mauro David J Chief Medical Officer | 2024-11-19 18:26:37 | 706,392 0 | 706,392 | Form 4 |
| Michor Franziska Director | 2024-11-22 18:25:51 | 251,468 0 | 251,468 | Form 4 |
| Doyle Ramona Chief Medical Officer | 2022-05-18 19:19:17 | 121,110 0 | 121,110 | Form 4 |
| Dar Zavain Director | 2024-10-04 18:30:19 | 106,225 0 | 106,225 | Form 4 |
| HERSHBERG ROBERT Director | 2024-06-05 18:12:17 | 77,909 0 | 77,909 | Form 4 |
| Burrell Terry-Ann Director | 2024-07-03 16:39:43 | 71,254 0 | 71,254 | Form 4 |
| CHAVEZ R. MARTIN Director | 2024-04-03 17:43:13 | 60,078 0 | 60,078 | Form 4 |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM LLC See remarks | 2021-11-03 17:17:13 | 0 0 | 0 | Form 4 |